Regentatlantic Capital LLC Moderna, Inc. Transaction History

Regentatlantic Capital LLC

$3.34 Billion
Q3 2022

A detailed history of Regentatlantic Capital LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Regentatlantic Capital LLC holds 11,193 shares of MRNA stock, worth $412,462. This represents 0.04% of its overall portfolio holdings.

Number of Shares

11,193

Previous 14,329 21.89%

Holding current value

$412,462

Previous $2.05 Million 35.32%

% of portfolio

0.04%

Previous 0.07%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$118.07 - $194.18 $370,267 - $608,948	-3,136 Reduced 21.89%	11,193 $1.32 Million
Q2 2022 Aug 15, 2022	BUY	$117.13 - $176.59 $8,433 - $12,714	72 Added 0.51%	14,329 $2.05 Million
Q1 2022 May 02, 2022	BUY	$126.46 - $235.05 $482,191 - $896,245	3,813 Added 36.51%	14,257 $2.46 Million
Q4 2021 Jan 27, 2022	SELL	$225.82 - $368.51 $679,266 - $1.11 Million	-3,008 Reduced 22.36%	10,444 $2.65 Million
Q3 2021 Nov 15, 2021	BUY	$221.9 - $484.47 $2.69 Million - $5.88 Million	12,135 Added 921.41%	13,452 $5.18 Million
Q2 2021 Aug 12, 2021	BUY	$129.91 - $234.98 $171,091 - $309,468	1,317 New	1,317 $309,000
Q1 2021 Apr 29, 2021	SELL	$109.18 - $185.98 $540,004 - $919,857	-4,946 Closed	0 $0
Q4 2020 Feb 04, 2021	SELL	$65.74 - $169.86 $100,910 - $260,735	-1,535 Reduced 23.68%	4,946 $517,000
Q3 2020 Oct 13, 2020	SELL	$54.34 - $94.85 $108 - $189	-2 Reduced 0.03%	6,481 $459,000
Q2 2020 Aug 13, 2020	SELL	$29.67 - $80.0 $120,282 - $324,320	-4,054 Reduced 38.47%	6,483 $416,000
Q1 2020 May 14, 2020	SELL	$17.78 - $31.58 $69,270 - $123,035	-3,896 Reduced 26.99%	10,537 $316,000
Q4 2019 Feb 04, 2020	SELL	$13.93 - $21.28 $27,860 - $42,560	-2,000 Reduced 12.17%	14,433 $282,000
Q3 2019 Oct 22, 2019	SELL	$12.26 - $18.07 $36,780 - $54,210	-3,000 Reduced 15.44%	16,433 $262,000
Q2 2019 Jul 23, 2019	BUY	$13.7 - $28.34 $266,232 - $550,731	19,433 New	19,433 $284,000

Others Institutions Holding MRNA

# of Institutions

954

Shares Held

241M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Regentatlantic Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Regentatlantic Capital LLC with notifications on news.

Account

Regentatlantic Capital LLC Moderna, Inc. Transaction History